Market Tracker

10/23 3:40am ET

Endocyte Inc (NASDAQ:ECYT)

5.63
Data as of Oct 22
 +0.05 / +0.90%
Today’s Change
5.31
Today|||52-Week Range
33.70
-47.28%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close5.58
Today’s open5.58
Day’s range-- - --
Volume642,516
Average volume (3 months)1,436,648
Market cap$231.9M
Dividend yield--
Data as of 10/22/2014

Growth & Valuation

Earnings growth (last year)-4.17%
Earnings growth (this year)+93.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+87.04%
P/E ratio20.9
Price/Sales5.93
Price/Book2.29

Competitors

 Today’s
change
Today’s
% change
MRTXMirati Therapeutics ...-0.33-1.93%
GALEGalena Biopharma Inc-0.06-3.12%
ADMSAdamas Pharmaceutica...-0.08-0.56%
CCXIChemoCentryx Inc+0.13+2.34%
Data as of 3:59pm ET, 10/22/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$64.9M
Annual profit (last year)-$18.0M
Net profit margin-27.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
P. Ron Ellis
Chief Operating &
Financial Officer
Michael A. Sherman
Corporate headquarters
West Lafayette, Indiana

Forecasts